Sangamo Therapeutics Inc (NAS:SGMO)
$ 2.16 0.42 (24.14%) Market Cap: 449.76 Mil Enterprise Value: 363.62 Mil PE Ratio: 0 PB Ratio: 19.64 GF Score: 42/100

Sangamo Therapeutics Inc at Barclays Global Healthcare Conference Transcript

Mar 11, 2020 / 12:30PM GMT
Release Date Price: $7.02 (-7.51%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Thank you, everyone. My name is Gena Wang. I'm SMID Cap Biotech Analyst at the Barclays. I first hope everyone stay healthy. I would like to thank all the participants, investors, companies, especially our event team and the corporate access team who made this virtual healthcare conference possible.

With that, I would like to introduce our next speakers from Sangamo, we have Sandy Macrae, Chief Executive Officer; Sung Lee, Chief Financial Officer; McDavid Stilwell, Senior VP Corporate Communication and Investor Relations; and also James Chen of Director of IR.

Sandy, I will hand over to you.

Alexander D. Macrae
Sangamo Therapeutics, Inc. - CEO, President & Director

Thanks, Gena, and thanks to you all for being on the call. I would refer you all as always to our forward-looking statements. And so I'm going to go through a short deck of slides here and then would be happy to answer some questions from Gena.

So we are Sangamo, Sangamo Therapeutics, and we are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot